ARCHIVES

In Setback For Generics, Court Overturns FDA.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

TA To Release Report On Burton Therapy Requested By Congress

February 9, 1990

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

In Brief: NCI-Litton Negations On Frederick continue; Staffs Not Worried About Possible GAO Probe

July 15, 1977

Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.

February 25, 2000